Elevation of clonal serum free light chains in patients with HIV-negative primary effusion lymphoma (PEL) and PEL-like lymphoma

British Journal of Haematology

Volumn 147, Issue 3, 2009, Pages 405-408

  De Filippi, Rosaria ^a,b   Iaccarino, Giancarla ^a   Frigeri, Ferdinando ^a   Di Francia, Raffaele ^a   Crisci, Stefania ^a   Capobianco, Gaetana ^a   Arcamone, Manuela ^a   Becchimanzi, Cristina ^a   Amoroso, Barbara ^c   De Chiara, Annarosaria ^a   Corazzelli, Gaetano ^a   Pinto, Antonio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Binding Site Group Ltd   (United Kingdom)

Author keywords

Bortezomib; Primary effusion lymphoma; Serum free light chains; Thalidomide

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN; PREDNISONE; THALIDOMIDE; VINCRISTINE;

AGED; ASCITES; CANCER CHEMOTHERAPY; CASE REPORT; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HEAVY CHAIN; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LETTER; LIGHT CHAIN; MALE; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; PLEURA EFFUSION; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR CELL; TUMOR GROWTH;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HIV SERONEGATIVITY; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; LYMPHOMA, PRIMARY EFFUSION; MALE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 70349898279     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07846.x     Document Type: Letter

References (10)

1. Arguello, M., Sgarbanti, M., Hernandez, E., Mamane, Y., Sharma, S., Servant, M., Lin, R. Hiscott, J. (2003) Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. Oncogene, 22, 964 973.
2. Boulanger, E., Gerard, L., Gabarre, J., Molina, J.M., Rapp, C., Abino, J.F., Cadranel, J., Chevret, S. Oksenhendler, E. (2005) Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. Journal of Clinical Oncology, 23, 4372 4380.
3. Carbone, A. Gloghini, A. (2008) KSHV/HHV8-associated lymphomas. British Journal of Haematology, 140, 13 24.
4. Di Bartolo, D.L., Hyjek, E., Keller, S., Guasparri, I., Deng, H., Sun, R., Chadburn, A., Knowles, D.M. Cesarman, E. (2009) Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma. Journal of Virology, 83, 4308 4315.
5. Jenner, R.G., Maillard, K., Cattini, N., Weiss, R.A., Boshoff, C., Wooster, R. Kellam, P. (2003) Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proceedings of the National Academy of Sciences of the United States of America, 100, 10399 10404.
6. Kobayashi, Y., Kamitsuji, Y., Kuroda, J., Tsunoda, S., Uoshima, N., Kimura, S., Wada, K., Matsumoto, Y., Nomura, K., Horiike, S., Shimazaki, C., Yoshikawa, T. Taniwaki, M. (2007) Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature. Acta Haematologica, 117, 132 144.
7. Nador, R.G., Cesarman, E., Chadburn, A., Dawson, D.B., Ansari, M.Q., Sald, J. Knowles, D.M. (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood, 88, 645 656.
8. Paner, G.P., Jensen, J., Foreman, K.E. Reyes, C.V. (2003) HIV and HHV-8 negative primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis. Leukaemia & Lymphoma, 44, 1811 1814.
9. Pratt, G. (2008) The evolving use of serum free light chain assays in haematology. British Journal of Haematology, 141, 413 422.
10. Wakely, Jr., P.E., Menezes, G. Nuovo, G.J. (2002) Primary effusion lymphoma: cytopathologic diagnosis using in situ molecular genetic analysis for human herpesvirus 8. Modern Pathology, 15, 944 950.